BioCentury This WeekWUSA9
About The Show Meet The Team Program Archive Become a Sponsor
      HOME     ABOUT BIOCENTURY     WHY BCTV?     PRESS RELEASES    FREE CONTENT    LINK TO BCTV    CONTACT US   
Advertisement
Advertisement

Free Content

Use our marquee links to make BioCentury This Week part of your home page! Our player style marquee links below make it very easy to do.

Your Webmaster can follow these easy steps:

  1. Select the program from the list below to which you want to link.
  2. Copy the html code in the box for that segment.
  3. Paste the copied html code into your home page.

If you want to link to multiple segments, select the first of your choices as the marquee link. The segments that follow will play automatically after your selection.

Questions: jfitzgerald@biocentury.com

That's it! You now have a marquee link like the one above.

NOTICE:
BioCentury Publications, Inc., and WUSA-TV own the copyright to the program content on "BioCentury This Week," and except for limited use of these links to the BioCenturytv.com website, BioCentury and WUSA prohibit hosting of BioCentury This Week program content by unauthorized third parties or posting of BioCentury This Week content to any unauthorized third party websites such as YouTube. Other BioCenturytv.com content and all trademarks are the property of BioCentury or WUSA-TV or other third parties.

Questions on authorized use may be directed to jfitzgerald@biocentury.com

 
BioCentury 12.21.14 - [1] A Different Response
BioCentury 12.21.14 - [1] A Different Response
How outliers, patients who repond exceptionally well to treatment, are driving the search for new cancer therapies. Guests: NCI's Dr. Mary Conley and Dr. Malcom Smith, Dr. Bert Thomas of the Sarcoma Foundation of America.
COPY THIS CODE:
 
 
BioCentury 12.21.14 - [2] MATCH Study
BioCentury 12.21.14 - [2] MATCH Study
MATCH studies link targeted therapies to adults and children with progressing cancers. Dr. Mary Conley: "We will biopsy their tumor and sequence it and have up to 20 combinations of drugs that would be targeted to the mutation they have."
COPY THIS CODE:
 
 
BioCentury 12.21.14 - [3] Pediatric MATCH
BioCentury 12.21.14 - [3] Pediatric MATCH
Dr. Malcom Smith on the pediatric MATCH study "NCI will establish agreements with a number of different drug companies to get relevant agents that are against the appropriate targets."
COPY THIS CODE:
 
 
BioCentury 12.21.14 - [4] What Are They Saying?
BioCentury 12.21.14 - [4] What Are They Saying?
The Sarcoma Foundation's Dr. Bert Thomas: "When you have an exceptional responder, you have someone who is telling you there is something different about my tumor, the way I'm reacting to that drug."
COPY THIS CODE:
 
User Agreement | Terms of Use | Privacy Policy | Your California Privacy Rights | Use of Images

Advertisement